ClaripulseClaripulse™
Get Early Access
Back to Coronary Intervention

Endeavor sprint Adverse Events: FDA MAUDE Data

MEDTRONIC, INC. · Coronary Drug-Eluting Stent · First cleared Feb 2008

Total Reports

147

Reports (30d)

0

Active Signals

0

Open Recalls

0

Monthly Report Volume
Event Type Breakdown

Evidence

Related research

Polymer-based or Polymer-free Stents in Patients at High Bleeding Risk

Stephan Windecker, et al. · New England Journal of Medicine · 2020

Citations indexed from PubMed.

Keep exploring

Related devices in Coronary

Perclose ProGlide

ABBOTT VASCULAR INC. · 24,635 reports

→

Perclose ProStyle

ABBOTT VASCULAR INC. · 19,655 reports

→

PERCLOSE

ABBOTT VASCULAR INC. · 10,082 reports

→

Angio-Seal

TERUMO MEDICAL CORPORATION · 6,727 reports

→

SYNERGY

BOSTON SCIENTIFIC CORPORATION · 6,095 reports

→

Resolute Onyx

MEDTRONIC, INC. · 4,494 reports

→

Want automated safety signal detection?

Claripulse monitors these devices weekly and detects anomalies using 6 statistical methods — spike, trend, changepoint, peer-outlier, and more.

Get Early Access

Understanding this data

What FDA MAUDE data does and does not tell you

How these reports are filed, why raw counts mislead, and the limits to know before drawing conclusions.

→

How a safety signal is detected

What the "Active Signals" count above means and the methods that separate a real signal from noise.

→
Disclaimer: This system analyzes publicly available FDA MAUDE data. It does NOT provide medical advice. MAUDE data is de-identified. Do not attempt re-identification. Report counts may differ from the FDA's MAUDE search due to processing cadence and deduplication. Data is updated weekly.